India's latest amendment to its Patent Act revolutionized the country's IP regime by
introducing a product patent for pharmaceuticals. Ahibhusan De and Uma Baskaran
of Krishna and Saurastri explain what the new rules mean in practice
Unlock this article.
The content you are trying to view is exclusive to our subscribers.